Home › NDC Lookup › RxCUI directory › RxCUI 2282313

Rimegepant 75 MG Disintegrating Oral Tablet — RxCUI 2282313

RxNorm drug concept · Semantic clinical drug
RxCUI 2282313 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2282313
Official nameRimegepant 75 MG Disintegrating Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asrimegepant 75 MG (as rimegepant sulfate 85.65 MG) Disintegrating Oral Tablet
FDA products mapped3
Package NDCs mapped4
Reported Medicaid activity (SDUD)492,967 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Rimegepant: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Nurtec ODT is actually approved for both purposes — stopping a migraine once it starts AND preventing future ones. If you're using it for prevention, you take it every other day on...
  • Can I use Nurtec ODT to both treat and prevent my migraines, or do I have to pick one?
  • Nurtec ODT is an orally disintegrating tablet, which means it dissolves right on your tongue — no water needed. Open the blister pack by peeling back the foil (don't push the table...
  • How do I take this tablet? It looks different from a regular pill.
📖 Read our full Rimegepant guide →

🕸️ Concept Web — How Rimegepant 75 MG Disintegrating Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Rimegepant 75 MG Disintegrating Oral Tablet RxCUI 2282313

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Rimegepant 2282307
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Nurtec 2282314
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Rimegepant Disintegrating Oral Tablet 2618951
    • Rimegepant Disintegrating Oral Product 2618950
    • Rimegepant Oral Product 2618948
    • Rimegepant Pill 2618949
    • Rimegepant Disintegrating Oral Tablet [Nurtec] 2618954
    • Nurtec Disintegrating Oral Product 2282317
    • Nurtec Oral Product 2282318
    • Nurtec Pill 2282319
    • +4 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Rimegepant 75 MG SCDC · 2618947
  • Rimegepant Disintegrating Oral Tablet SCDF · 2618951
  • Rimegepant Disintegrating Oral Product SCDG · 2618950
  • Rimegepant Oral Product SCDG · 2618948
  • Rimegepant Pill SCDG · 2618949

Brand-Name Concepts

  • Rimegepant 75 MG Disintegrating Oral Tablet [Nurtec] SBD · 2282320
  • Rimegepant 75 MG [Nurtec] SBDC · 2618953
  • Rimegepant Disintegrating Oral Tablet [Nurtec] SBDF · 2618954
  • Nurtec Disintegrating Oral Product SBDG · 2282317
  • Nurtec Oral Product SBDG · 2282318
  • Nurtec Pill SBDG · 2282319
  • Nurtec BN · 2282314

📦 FDA Products & Package NDCs

3 products · 4 package NDCs
4 package NDCs map to RxCUI 2282313 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
72618-3000-02 1 BLISTER PACK in 1 CARTON (72618-3000-2) / 8 TABLET, ORALL... NURTEC ODT Pfizer Laboratories Div Pfizer Inc 2020-03-05
72618-3001-02 4 DOSE PACK in 1 CARTON (72618-3001-2) / 1 BLISTER PACK in... NURTEC ODT Pfizer Laboratories Div Pfizer Inc 2020-03-05
72618-3001-04 1 BLISTER PACK in 1 CARTON (72618-3001-4) / 2 TABLET, ORALL... NURTEC ODT Pfizer Laboratories Div Pfizer Inc 2024-12-18
85766-0096-08 1 BLISTER PACK in 1 CARTON (85766-096-08) / 8 TABLET, ORALL... NURTEC ODT Sportpharm LLC 2025-10-14
Observed labelers: Pfizer Laboratories Div Pfizer Inc (3) · Sportpharm LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$128.7110
Range $128.7110–$128.7110 · middle 50% $128.7110–$128.7110 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.